The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-30), PetVivo Holdings's share price is $0.82. PetVivo Holdings's Book Value per Share for the quarter that ended in Dec. 2023 was $0.06. Hence, PetVivo Holdings's PB Ratio of today is 13.67.
The historical rank and industry rank for PetVivo Holdings's PB Ratio or its related term are showing as below:
PETV'
s PB Ratio Range Over the Past 10 Years
Min: 1.71 Med: 45.54 Max: 314.18
Current: 13.67
During the past 13 years, PetVivo Holdings's highest PB Ratio was 314.18. The lowest was 1.71. And the median was 45.54.
PETV's PB Ratio is ranked worse than 95.35% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 2.2
vs PETV: 13.67
During the past 12 months, PetVivo Holdings's average Book Value Per Share Growth Rate was -23.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PetVivo Holdings was 73.90% per year. The lowest was -229.90% per year. And the median was 11.65% per year.
Back to Basics: PB Ratio
PetVivo Holdings PB Ratio Historical Data
The historical data trend for PetVivo Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PetVivo Holdings's PB Ratio
For the Medical Devices subindustry, PetVivo Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's PB Ratio falls into.
PetVivo Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PetVivo Holdings (OTCPK:PETV) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PetVivo Holdings PB Ratio Related Terms
Thank you for viewing the detailed overview of PetVivo Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
PetVivo Holdings (PetVivo Holdings) Business Description
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PETV has been successfully added to your 